Imbed Biosciences

Imbed Biosciences develops and manufactures advanced biomaterials for soft-tissue repair, including the world's first fully-synthetic and antimicrobial wound matrix. Their FDA-cleared Microlyte® Matrix technology accelerates wound healing and reduces infection risk, improving patient outcomes. The company focuses on solutions for burns, skin grafts, chronic, and surgical wounds.

Funding Round: Growth Funding

Funding Amount: $10M

Date: 08-Jan-2024

Investors: Niterra, Pegasus Tech Ventures

Markets: Biotechnology, Medical Devices, Wound Care, Nanocoatings, Silver nanoparticles, Biotech, Surgical

HQ: Middleton, Wisconsin, United States

Founded: 2010

Website: https://www.imbedbio.com/

LinkedIn: https://www.linkedin.com/company/imbed-biosciences-inc

Twitter: http://twitter.com/imbedbio

Instagram:

Facebook: https://www.facebook.com/imbedbio/